Health News News 7 November 2025

Bupa renews ParalympicsGB partnership and seals Nuffield Health deal as robotic knee surgery hits 1,000 mark

NEW YORK, January 1, 2026, 06:51 ET Bupa UK on Wednesday renewed its role as Official Healthcare Partner of ParalympicsGB and agreed a new three-year contract between Bupa UK Insurance and Nuffield Health, the company said. The Nuffield agreement adds

1 January 2026

Corporate Deals·Health News·Medical Technology

Axsome stock jumps nearly 23% after FDA fast-tracks AXS-05 for Alzheimer’s agitation

NEW YORK, December 31, 2025, 19:19 ET — After-hours Axsome Therapeutics, Inc. shares jumped 22.9% to $182.64 in after-hours trading on Wednesday after the company said the U.S. Food and Drug Administration accepted its supplemental New Drug Application for AXS-05

1 January 2026

FDA Approvals·Health News·Pharmaceuticals·Stock Market

Structure Therapeutics (GPCR) Stock News and Forecasts on Dec. 23, 2025: Oral Obesity Pipeline, Capital Raise, Analyst Targets, and What Comes Next

Structure Therapeutics Inc. (NASDAQ: GPCR) is ending 2025 in the middle of one of biotech’s hottest battlegrounds: oral weight-loss medicines. As of Dec. 23, 2025, GPCR shares were trading around $67.50 in U.S. session data, after a volatile stretch driven

23 December 2025

Biotechnology·Health News·Investment Analysis·Pharmaceuticals·Stock Market

FDA Approves Wegovy Pill: Novo Nordisk’s Oral Semaglutide Launch Ignites a 2026 Weight‑Loss Drug Showdown

On December 22, 2025, Novo Nordisk won one of the most consequential regulatory decisions in modern obesity medicine: U.S. FDA approval of a once‑daily “Wegovy pill” (oral semaglutide 25 mg) for chronic weight management—marking the first oral GLP‑1 authorized in

23 December 2025

Health News·Pharmaceuticals

So Delicious Dairy Free Ice Cream Recall: Danone Pulls Salted Caramel Cluster Pints Over Possible “Small Stones” (Dec. 17, 2025)

December 17, 2025 — If you keep dairy-free frozen treats stocked for the holidays, it’s worth taking a quick look in your freezer. Danone U.S. has issued a voluntary nationwide recall for specific pints of So Delicious Dairy Free Salted

18 December 2025

Health News

California Vega Farms Egg Recall: 63 Sick, 13 Hospitalized in Salmonella Outbreak—How to Identify Affected Eggs

SACRAMENTO, Calif. (Dec. 15, 2025) — A Salmonella Enteritidis outbreak in California has been linked to recalled Vega Farms in-shell brown eggs, with state health officials reporting 63 illnesses and 13 hospitalizations (and no deaths) tied to the outbreak strain

16 December 2025

Health News

Vega Farms Egg Recall Update: California Links Salmonella Outbreak to Dixon Farm Eggs; 63 Sick, 13 Hospitalized

SACRAMENTO, Calif. (Dec. 13, 2025) — California health officials are urging residents and businesses across parts of Northern California to stop eating, selling, or serving certain Vega Farms in-shell eggs after the products were linked to a Salmonella Enteritidis outbreak

13 December 2025

Health News

McCain Pizza Pockets Recall Australia 2025: Cheese & Bacon 400g Pulled from Woolworths, Coles and IGA After Plastic and Metal Contamination Warning

Australians are being urged to check their freezers after McCain Foods (Aust) Pty Ltd issued a nationwide recall for McCain Cheese & Bacon Pizza Pockets (400g) following reports of foreign material in the product. The recall, published on Friday, 12

12 December 2025

Health News

Johnson & Johnson (JNJ) Stock After Hours on December 9, 2025: New Cancer Breakthrough, Dividend Payout and What to Watch Before the December 10 Open

Key Takeaways Below, we’ll walk through what happened to Johnson & Johnson stock after the bell on December 9 and what investors should watch before the U.S. market opens on Wednesday, December 10, 2025. 1. How Johnson & Johnson Stock

10 December 2025

Cancer Research·Dividends·Health News·Investment Tips·Stock Market

Moderna (MRNA) Stock Jumps on New Vaccine Safety Data – Latest News, Forecast & Analysis for December 5, 2025

Moderna, Inc. (NASDAQ: MRNA) closed today as one of the more talked‑about healthcare names on Wall Street, with the stock rebounding sharply after a bruising year of falling COVID-19 vaccine sales, pipeline setbacks, and rising regulatory risk. Today’s move comes

5 December 2025

Biotechnology·Health News·Investing·Market Analysis·Stocks

Intellia Therapeutics (NTLA) plunges after patient death in pivotal CRISPR trial; Q3 update, analyst downgrades and what to watch next [Nov. 7, 2025]

What happened today Intellia Therapeutics (NASDAQ: NTLA) is under intense pressure after the company said the patient who experienced Grade 4 liver enzyme and bilirubin elevations in its Phase 3 MAGNITUDE study later died. In a Nov. 6 business update,

7 November 2025

Biotechnology·Clinical Trials·Health News·Stock Market

Health News News 7 November 2025 - 1 January 2026